Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, talks about how data on the LGBTQ+ community in the neurology space is needed in order to provide effective value-based health care.
More data is needed in order to provide true value-based care to LGBTQ+ community memebers, says Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist.
Transcript
How can value-based health care methods help the LGBTQ+ community in the neurology space?
This is such an important question, and I think the idea of value-based care has a lot of momentum behind it. The challenge is that value-based care requires data. It requires measurement of outcomes; reporting back continual iteration of the process to improve the quality of care. The challenge is with that measurement piece, and so not very many folks collect sexual orientation or gender identity in their data routinely. So, we don't have that first part; we don't have the data to go into the process, to talk about outcomes, to talk about how we can do better for service for the community and access and outcomes within care. So, I think that really working on that first step is going to hopefully drive us towards be able to actually provide value-based care for LGBTQ individuals.
Supplemental Breast Cancer Screening Law Renders Many High-Risk Black Women Ineligible
August 5th 2025The Pennsylvania Act 1 of 2023 eligibility criteria for supplemental screenings based on breast density and lifetime risk of breast cancer disproportionately disqualify Black women from supplemental screenings despite their high risk of aggressive cancer and persistent history of false-negative mammograms.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More